文献速递儿童青少年精神

新生儿细胞因子与趋化因子作为孤独症风险预测因子的探索性研究

An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study.
PubMed 文献 · Biol Psychiatry · 2019-05-15

该研究基于Early Markers for Autism人群病例对照研究,检测孤独症谱系障碍(ASD)儿童、发育迟缓儿童和一般人群对照的新生儿血斑中42种免疫标志物。结果显示ASD儿童新生儿IL-6和IL-8水平显著高于一般人群对照,尤其早发型ASD中IL-8升高显著(调整OR=1.97,95%CI 1.39-2.83,p=.00014)。探索性提示新生儿血斑炎症标志物可能有助于出生时评估ASD风险。

要点

  • ASD儿童新生儿IL-6和IL-8水平显著高于一般人群对照。
  • 早发型ASD中IL-8升高显著,调整OR=1.97(95%CI 1.39-2.83,p=.00014)。
  • ASD儿童相对发育迟缓儿童eotaxin-1、IFN-γ和IL-12p70显著升高。

核心结论

  • 部分炎症标志物在新生儿血斑中升高,提示 subsequently 诊断为ASD的儿童出生时存在较高程度免疫激活。
  • 探索性数据提示扩展后新生儿血斑细胞因子/趋化因子检测可能有助于出生时准确评估ASD风险。

研究设计与样本

  • 数据来自Early Markers for Autism研究,为基于人群的病例对照研究,检测产前和新生儿ASD生物标志物。
  • 纳入ASD儿童n=370、发育迟缓儿童n=140、一般人群对照n=378,使用Luminex多重平台分析新生儿血斑42种免疫标志物。

主要发现

  • ASD儿童新生儿IL-6和IL-8水平显著高于一般人群对照。
  • 早发型ASD组IL-8较一般人群对照升高尤为显著,调整OR=1.97(95%CI 1.39-2.83,p=.00014)。
  • ASD儿童相对发育迟缓儿童eotaxin-1、干扰素-γ和IL-12p70水平显著升高。
  • 发育迟缓组与一般人群对照组之间免疫标志物水平无显著差异。

关键数值与推荐

  • ASD与一般人群对照比较采用逻辑回归和偏最小二乘判别分析。
  • 早发型ASD与一般人群对照的IL-8比较:调整OR=1.97(95%CI 1.39-2.83,p=.00014)。

临床怎么用

  • 目前仅作探索性证据,不推荐将新生儿细胞因子/趋化因子检测用于临床ASD风险预测。
  • 结果提示出生时免疫激活可能与后续ASD诊断相关,可供进一步生物标志物研究参考。

局限性

  • 原文标明为探索性研究,需进一步扩展验证。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The identification of an early biomarker for autism spectrum disorder (ASD) would improve the determination of risk, leading to earlier diagnosis and, potentially, earlier intervention and improved outcomes. METHODS: Data were generated from the Early Markers for Autism study, a population-based case-control study of prenatal and neonatal biomarkers of ASD. Newborn bloodspots of children with ASD (n = 370), children with developmental delay (n = 140), and general population (GP) controls (n = 378) were analyzed for 42 different immune markers using a Luminex multiplex platform. Comparisons of immune marker concentrations between groups were examined using logistic regression and partial least squares discriminant analysis. RESULTS: Children with ASD had significantly increased neonatal levels of interleukin-6 (IL-6) and IL-8 compared with GP controls. An increase in IL-8 was especially significant in the ASD group with early onset compared with the GP group, with an adjusted odds ratio of 1.97 (95% confidence interval, 1.39-2.83; p = .00014). In addition, children with ASD had significantly elevated levels of eotaxin-1, interferon-γ, and IL-12p70 relative to children with developmental delay. We observed no significant differences in levels of immune markers between the developmental delay and GP groups. CONCLUSIONS: Elevated levels of some inflammatory markers in newborn bloodspots indicated a higher degree of immune activation at birth in children who were subsequently diagnosed with ASD. The data from this exploratory study suggest that with further expansion, the development of neonatal bloodspot testing for cytokine/chemokine levels might lead to the identification of biomarkers that provide an accurate assessment of ASD risk at birth.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Heuer LS, Croen LA, Jones KL, et al. An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study. Biol Psychiatry. 2019. PMID: 31279535. doi:10.1016/j.biopsych.2019.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。